1
Clinical Trials associated with ZH9PAA Phase I, Randomised, Double-blind, Placebo-controlled, Parallel Group Dose Escalation Study to Evaluate the Safety, Tolerability and Immunogenicity of a Potential Oral Enteric Fever Vaccine (ZH9 + ZH9PA) in Healthy Participants
A Phase 1, randomised, double-blind, placebo-controlled, parallel group study in 45 healthy participants aged 18 to 45 years inclusive.
100 Clinical Results associated with ZH9PA
100 Translational Medicine associated with ZH9PA
100 Patents (Medical) associated with ZH9PA
100 Deals associated with ZH9PA